Testing effectiveness (Phase 2)WithdrawnNCT01913067
What this trial is testing
Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLC
Who this might be right for
Brain MetastasisBreast CancerNon Small Cell Lung Cancer
Jules Bordet Institute